Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andreas Grauer currently holds 35,000 shares of Sagimet Biosciences Inc. (SGMT), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Andreas Grauer has been a net neutral trader of SGMT stock. They have purchased $0 and sold $0 worth of shares.
Andreas Grauer's most recent insider trade was on May 28, 2026, when they sold 35,000 shares at $0.00 per share.
Andreas Grauer serves as Chief Medical Officer at Sagimet Biosciences Inc. (SGMT). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Andreas Grauer holds the position of Chief Medical Officer at Sagimet Biosciences Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Andreas Grauer has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Andreas Grauer was on May 28, 2026, when they purchased $0 worth of SGMT shares. This transaction involved 35,000 shares at N/A per share.
Andreas Grauer currently owns 35,000 shares of Sagimet Biosciences Inc. (SGMT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andreas Grauer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andreas Grauer has 2 Form 4 filings on record as an insider at Sagimet Biosciences Inc..
Set alerts for Andreas Grauer and 40,000+ other insiders.